Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINIRIN test: sublingual versus intravenous desmopressin in children with partial von Willebrand factor deficiency
MOH_2018-12-18_001950Phase 2Not yet recruiting
- Sponsor
- ד"ר עבד אבו קוידר
- Start
- Oct 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of desmopressin in von Willebrand disease (VWD), sponsored by ד"ר עבד אבו קוידר. Primary endpoint: Change in von Willebrand factor level after desmopressin challenge. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
desmopressin
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on MOH_2018-12-18_001950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-12-18_001950.